Spruce Biosciences
SPRB
31 hedge funds and large institutions have $3.03M invested in Spruce Biosciences in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 31 → 31 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.76% less ownership
Funds ownership: 27.07% → 25.31% (-1.8%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
35% less capital invested
Capital invested by funds: $4.69M → $3.03M (-$1.66M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$17.7K |
| 2 |
VF
Virtu Financial
New York
|
+$14.7K |
| 3 |
Jane Street
New York
|
+$13.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.3K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$6.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCV
Sands Capital Ventures
Arlington,
Virginia
|
-$301K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.8K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$17.7K |
| 4 |
HF
HRT Financial
New York
|
-$15K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$14.7K |
SPRB Hedge Fund Activity: Q1 2025 in Review
31 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q1 2025, worth a combined $3.03M — down 35% from $4.69M a quarter earlier.
Fund positioning in SPRB was balanced in Q1 2025: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 5 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $17.7K. The largest seller was Sands Capital Ventures, exiting entirely with an estimated $301K sold.
- 31 institutional investors held Spruce Biosciences (SPRB) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $3.03M of Spruce Biosciences stock for Q1 2025, down 35% quarter-over-quarter.
- 5 funds opened new Spruce Biosciences positions in Q1 2025 and 5 closed out, a net change of 0 holders.
- The largest Spruce Biosciences buyer in Q1 2025 was Two Sigma Securities, an estimated $17.7K added.
- The largest Spruce Biosciences seller in Q1 2025 was Sands Capital Ventures, an estimated $301K sold.
Based on aggregated 13F filings for Q1 2025.